Conmed

Conmed Stock-Based Compensation

The Stock-Based Compensation (SBC) of Conmed (CNMD) as of Nov 13, 2026 is 28.32 M USD. In the previous year, Stock-Based Compensation (SBC) was 25.56 M USD — a change of 10.82% (higher).

Stock-Based Compensation

28.32 MUSD

YoY

10.82%

Last updated:

Stock-Based Compensation (SBC) of Conmed is 2025 28.32 M USD. Stock-Based Compensation (SBC) of Conmed was 2024 25.56 M USD. It decreases by 10.82% higher compared to the previous year.

The Conmed Stock-Based Compensation history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Stock-Based Compensation
Date
Stock-Based Compensation
Jan 1, 2018
10.04 M USD
Jan 1, 2019
11.78 M USD
Jan 1, 2020
13.11 M USD
Jan 1, 2021
16.34 M USD
Jan 1, 2022
21.73 M USD
Jan 1, 2023
24.26 M USD
Jan 1, 2024
25.56 M USD
Jan 1, 2025
28.32 M USD
The Conmed Stock-Based Compensation history
YEARStock-Based CompensationYoY
28.32 MUSD+10.82%
25.56 MUSD+5.36%
24.26 MUSD+11.63%
21.73 MUSD+33.02%
16.34 MUSD+24.59%
13.11 MUSD+11.31%
11.78 MUSD+17.36%
10.04 MUSD+18.47%
8.47 MUSD+1.16%
8.38 MUSD+11.68%
7.50 MUSD-19.62%
9.33 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Conmed Stock analysis

What does Conmed do? Conmed Corporation is a leading medical technology company that offers a wide range of surgical instruments and devices for the fields of gastroenterology, endoscopy, orthopedics, gynecology, and electro surgery. The company was founded in 1970 and is headquartered in Utica, New York. The history of Conmed Corp began with the founding of Consolidated Medical Equipment, Inc. (CME) in 1970. The company initially started its business with the distribution of surgical instruments and devices for medical applications and quickly expanded in this field. In the 1980s, the company went public. In the 1990s, the company changed its name to Conmed Corporation and expanded its activities into the field of electro surgery, which has since become a major growth driver for the company. Today, Conmed Corp operates multiple manufacturing facilities worldwide and has sales offices in over 50 countries. The company is divided into four main business segments: gastroenterology, endoscopy, orthopedics, and electro surgery. The gastroenterology segment includes products for the diagnosis and treatment of gastrointestinal disorders, such as endoscopes, biopsy instruments, dilation balloons, trocars, and shears. In the endoscopy segment, Conmed Corp offers products for the diagnosis and treatment of digestive tract disorders, including endoscopes, biopsy instruments, dilation balloons, trocars, and shears. The orthopedics segment includes a wide range of surgical instruments and devices for the treatment of musculoskeletal disorders, including implants, bandages, bone plates, intramedullary nails, and others. Finally, the electro surgery segment is the fastest-growing segment of Conmed Corp and includes a wide range of devices for precision surgery, including electrocautery, electro surgery, endoscopy, and laparoscopy devices. Conmed Corp aims to develop innovative medical technologies that meet the needs of patients and healthcare professionals. The company places great emphasis on producing high-quality products that are reliable and safe. Conmed Corp is a successful company that continues to evolve and expand its product range to meet the rapidly evolving needs of the medical community. Conmed is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Conmed stock

Stock-Based Compensation (SBC) of Conmed is 28.32 M USD in 2025.

Stock-Based Compensation (SBC) of Conmed changed from 25.56 M USD to 28.32 M USD, representing a 10.82% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Stock-Based Compensation (SBC) Conmed since 2006 – with annual values, charts, and detailed analysis.

Stock-based compensation is a non-cash expense representing equity awards to employees. High SBC can dilute existing shareholders and inflate reported cash flow.

Stock-Based Compensation (SBC)'s USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Stock-Based Compensation (SBC)'s Conmed historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Conmed

All Key Metrics — Conmed